Professor Francesco Stellacci, EPFL
Serial startup founder, spinning innovative science & technology out of prominent research laboratories. Over $100M raised. Experienced in company formation, fundraising, team-building and cross-border organisation. Multiple licensing, collaboration & financing transactions negotiated and closed. Former EPFL Engineering Dean Adjunct.
Infectious Disease physician with 27 years of clinical drug development experience in large Pharma and biotech start-up companies. Experienced in the creation of drug development programs, protocols, and related documents. Multiple INDs and interactions with regulatory authorities worldwide. Clinical Professor of Pediatrics at the University of North Carolina.
Jones, S. T., et al. "Modified cyclodextrins as broad-spectrum antivirals." Science Advances, 2020
Kocabiyic, O., et al. "Non-Toxic Virucidal Macromolecules Show High Efficiency Against Influenza Virus Ex Vivo and In Vivo" Advanced Science, 2020